
The Swiss pharmaceutical firm Roche has received an emergency authorization from the US Food and Drug Administration (US FDA) for LightMix Ebola Zaire test for emergency use on patients with signs and symptoms of the deadly virus.
Mobile laboratories in Guinea, Sierra Leone and Liberia currently use expensive and time-consuming tests that can take up to six hours. However, the new test can take as little as three hours.
The Ebola test, manufactured by German company TIB MOLBIOL GmbH, has also been given the European CE mark indicating it abides with the EU regulations.
Source: Medindia
Advertisement
|
Recommended Readings
Latest Drug News




